Tempest Therapeutics announces 1-for-13 reverse stock split effective April 8, 2025

Tempest Therapeutics, Inc.

Reverse stock split at 1:13 ratio, effective 5:00 p.m. ET on April 8, 2025.
Pre-split shares outstanding: 45,764,184; post-split approx. 3,520,321 shares.
No fractional shares; cash payments in lieu of fractional shares.
Trading on Nasdaq Capital Market on split-adjusted basis from April 9, 2025.
Proportional adjustments to warrants/options exercise prices and shares reserved.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.